Global Preimplantation Genetic Diagnosis (Pgd) Market | Share, Size, Trends, Growth and Analysis to 2024 by Hexa Reports

Submitted by: Submitted by

Views: 10

Words: 941

Pages: 4

Category: Business and Industry

Date Submitted: 09/20/2016 02:51 AM

Report This Essay

Hexa Reports

Market Research Reports and Insightful Company Profiles

Preimplantation Genetic Diagnosis (PGD) Market Analysis,

Share and Size, Emerging Trends, Overview and Outlook,

Growth And Segment Forecasts To 2024

Global preimplantation genetic diagnosisis market expected to reach USD 96.8 million by 2024,

according to a new report by Grand View Research, Inc. This expected growth in demand can be

ascribed to the growing incidence of inherited single gene associated and late onset genetic disorders.

Ongoing introduction of advancements in in-vitro fertilization (IVF) methods are key factors that have a

positive impact on the growth of this market. Incorporation of novel algorithms pertaining to genetic

diagnosis using NGS technology are expected to fuel demand in the coming years.

Browse Detail Report With TOC @

http://www.hexareports.com/report/preimplantation-genetic-diagnosis-market/details

Demand for successful embryo implantation in couples who are detected with certain chromosomal

aberrations or fertility problems are also factors anticipated to boost growth in demand over the

forecast period.

Further key findings from the study suggest:

Chromosomal abnormalities accounted for over 36% of the revenue generated in 2015. This large share

can be attributed to growing usage of PGD techniques for detection of aneuploidies that are observed in

higher aged maternal patients. Furthermore, presence of large product portfolio of different market

Hexa Reports

Market Research Reports and Insightful Company Profiles

players operating in chromosomal abnormality detection is responsible for large market share of this

technique.

Embryo HLA typing for stem cell therapy accounted for over 32% of the revenue generated in the

market for 2015. High incidence rate of single gene disorders and late onset hereditary oncology

diseases that need to be treated in order to curb the mortality rate are major driver for growth of this

segment.

Embryo implantation for treatment of...